Gewählte Publikation:
Groschner, K; Ulle, P; Brunner, F; Kukovetz, WR.
Interaction of DPI 201-106 with cardiac muscarinic receptors.
Eur J Pharmacol. 1989; 159(2):125-131
Doi: 10.1016/0014-2999(89)90696-1
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Führende Autor*innen der Med Uni Graz
-
Groschner Klaus
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The effects of the new cardiotonic compound, DPI 201-106, on muscarinic responses and muscarinic receptor binding were studied in the guinea pig heart. DPI 201-106 exerted a pronounced anticholinergic action in isolated auricles and a moderate one in papillary muscles, which resembled the pattern of a functional antagonism. However, in competition binding experiments, DPI 201-106 inhibited binding of the specific muscarinic antagonist [3H]NMS with equal potency in atrial and ventricular homogenates (apparent KI = 0.7 mumol/l in atria and 1.2 mumol/l in ventricles). At higher concentrations (greater than 3 mumol/l), DPI 201-106 slowed the dissociation of [3H]NMS from cardiac muscarinic receptors, indicating that DPI 201-106 affects in addition a site allosteric to the muscarinic receptor. It is concluded that DPI 201-106 is able to inhibit cholinergic responses in the heart, not only by a functional antagonism but also by direct interaction with muscarinic receptors.
- Find related publications in this database (using NLM MeSH Indexing)
-
Animals -
-
Atropine - pharmacology
-
Carbachol - pharmacology
-
Female -
-
Guinea Pigs -
-
Male -
-
Myocardium - metabolism
-
Papillary Muscles - drug effects Papillary Muscles - metabolism
-
Piperazines - pharmacology
-
Receptors, Muscarinic - drug effects Receptors, Muscarinic - metabolism